Skip to content

Compensatory Cognitive Training in Clinical High Risk Latino Youth

Compensatory Cognitive Training in Clinical High Risk Latino Youth

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02245607
Enrollment
120
Registered
2014-09-19
Start date
2014-10-31
Completion date
2021-02-01
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical High Risk, Prodromal, Psychosis, Schizophrenia

Keywords

Psychotic Disorders, Cognitive Training, Mental Disorders, Schizophrenia and Disorders with Psychotic Features

Brief summary

This is a randomized study to compare Compensatory Cognitive Training (CCT) versus Recreational Therapy (RT) in Latino clinical high risk individuals in the US and Mexico. Study hypotheses: Compared to those who receive RT, study participants receiving CCT will show significant improvement in neurocognition, functional capacity, self-rated functioning and clinical measures.

Detailed description

This is a 12 week randomized study to compare Compensatory Cognitive Training (CCT) versus Recreational Therapy (RT) in Latino clinical high risk individuals in the US and Mexico. Study participants will be measured 3 times, at baseline, 12 and 24 weeks on all outcome measures. Study hypothesis: Study participants receiving CCT will show significant improvement at 12 and 24 weeks compared to baseline in 1) Neurocognition using the Global Cognitive Index z score derived from the MATRICS neurocognitive domain scores, 2) Functional Capacity as assessed by the UCSD Performance-based Skills Assessment (UPSA/UPSA-Adolescent), 3) Self-Rated Functioning as measured by the Specific Level of Functioning Scale (SLoF) and 4) Clinical symptom ratings as measured by the Scale of Prodromal Symptoms (SOPS) total score when compared to subjects receiving RT training across study time.

Interventions

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* Meet Clinical High Risk criteria * Be of Latino descent * Speak Spanish as their preferred language

Exclusion criteria

* Concomitant medical or neurological illness * Brain injury with loss of consciousness \> 30 minutes * Current substance abuse (excluding nicotine) * IQ \< 80 * High suicidal risk

Design outcomes

Primary

MeasureTime frameDescription
Neurocognition (Global Cognitive Index z score)3 and 6 months post-baselineThe CGI is derived based on Z scores across multiple neurocognitive domains and is a representation of global cognition

Secondary

MeasureTime frameDescription
Functional capacity (UPSA/UPSA-A)3 and 6 month post-baselineThe UPSA total Functional Capacity score is the total of all subscale scores on the UPSA (Finances, Communication, Transportation, Household)

Other

MeasureTime frameDescription
Self-reported functioning (SLoF)3 and 6 month post-baselineThe specific level of functioning (SLOF) assessment scale measures observable behavioral functioning and daily living skills.
Clinical symptom severity (SOPS total)3 and 6 month post-baselineThe Scale of Prodromal Symptoms (SOPS) measures positive, negative, disorganized and general symptoms seen in psychotic illness. The total score is used for outcome.

Countries

Mexico, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026